Next Century Growth Investors’s Biogen BIIB Stock Holding History

Next Century Growth Investors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-7,741	Closed	-$3.13M	–	181
2015 Q2	$3.13M	Sell	7,741 -65	-0.8%	-$26.1K	0.11%	171
2015 Q1	$3.3M	Buy	+7,806	New	+$3.08M	0.12%	171
2014 Q2	–	Sell	-9,646	Closed	-$2.95M	–	183
2014 Q1	$2.95M	Buy	9,646 +507	+6%	+$161K	0.09%	171
2013 Q4	$2.56M	Buy	9,139 +60	+0.7%	+$15.5K	0.07%	167
2013 Q3	$2.19M	Sell	9,079 -126	-1%	-$28.2K	0.06%	162
2013 Q2	$1.98M	Buy	+9,205	New	+$1.97M	0.06%	157

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Next Century Growth Investors's BIIB Position: Q3 2015 in Review

Next Century Growth Investors sold out of Biogen (BIIB) in Q3 2015, closing a stake of 7,741 shares — an estimated $3.13M sold.

Next Century Growth Investors first reported a position in BIIB in Q2 2013 and held it in 6 quarters. The position peaked at $3.3M in Q1 2015. 923 funds tracked by Wall St. Rank hold BIIB as of Q3 2015.

Next Century Growth Investors reported no remaining Biogen position as of Q3 2015 after selling out during the quarter.
Next Century Growth Investors sold 7,741 Biogen shares in Q3 2015, an estimated $3.13M.
Next Century Growth Investors first reported a position in Biogen in Q2 2013 and held it in 6 quarters.
Next Century Growth Investors's Biogen position peaked at $3.3M in Q1 2015.
923 funds tracked by Wall St. Rank held Biogen as of Q3 2015.

Based on Next Century Growth Investors's 13F filing for Q3 2015, filed 13 Nov 2015.